These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8243814

  • 1. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM.
    Puhakainen I, Yki-Järvinen H.
    Diabetes; 1993 Dec; 42(12):1694-9. PubMed ID: 8243814
    [Abstract] [Full Text] [Related]

  • 2. Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.
    Fulcher GR, Walker M, Catalano C, Farrer M, Alberti KG.
    Clin Sci (Lond); 1992 May; 82(5):565-71. PubMed ID: 1317767
    [Abstract] [Full Text] [Related]

  • 3. Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.
    Yki-Järvinen H, Helve E, Sane T, Nurjhan N, Taskinen MR.
    Am J Physiol; 1989 Jun; 256(6 Pt 1):E732-9. PubMed ID: 2660587
    [Abstract] [Full Text] [Related]

  • 4. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.
    Saloranta C, Taskinen MR, Widen E, Härkönen M, Melander A, Groop L.
    Diabetes; 1993 Nov; 42(11):1559-66. PubMed ID: 8405695
    [Abstract] [Full Text] [Related]

  • 5. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients.
    Puhakainen I, Koivisto VA, Yki-Järvinen H.
    Diabetes; 1991 Oct; 40(10):1319-27. PubMed ID: 1936594
    [Abstract] [Full Text] [Related]

  • 6. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
    Fulcher GR, Walker M, Farrer M, Johnson AS, Alberti KG.
    Metabolism; 1993 Mar; 42(3):308-14. PubMed ID: 8487648
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [Abstract] [Full Text] [Related]

  • 8. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
    Fulcher GR, Walker M, Catalano C, Agius L, Alberti KG.
    Diabetes; 1992 Nov; 41(11):1400-8. PubMed ID: 1397716
    [Abstract] [Full Text] [Related]

  • 9. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
    Puhakainen I, Koivisto VA, Yki-Järvinen H.
    J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
    [Abstract] [Full Text] [Related]

  • 10. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
    Fanelli C, Calderone S, Epifano L, De Vincenzo A, Modarelli F, Pampanelli S, Perriello G, De Feo P, Brunetti P, Gerich JE.
    J Clin Invest; 1993 Oct; 92(4):1617-22. PubMed ID: 8408616
    [Abstract] [Full Text] [Related]

  • 11. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
    Cusi K, Consoli A, DeFronzo RA.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4059-67. PubMed ID: 8923861
    [Abstract] [Full Text] [Related]

  • 12. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
    Jenssen T, Nurjhan N, Consoli A, Gerich JE.
    J Clin Invest; 1990 Aug; 86(2):489-97. PubMed ID: 2200805
    [Abstract] [Full Text] [Related]

  • 13. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.
    Nurjhan N, Consoli A, Gerich J.
    J Clin Invest; 1992 Jan; 89(1):169-75. PubMed ID: 1729269
    [Abstract] [Full Text] [Related]

  • 14. The role of plasma non-esterified fatty acids during exercise in type 2 diabetes mellitus.
    Berrish TS, Elliott C, Cooper BG, Reed JW, Orskov H, Alberti KG, Walker M.
    Diabet Med; 1993 Mar; 10(2):152-8. PubMed ID: 8458192
    [Abstract] [Full Text] [Related]

  • 15. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
    Worm D, Henriksen JE, Vaag A, Thye-Rønn P, Melander A, Beck-Nielsen H.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):717-21. PubMed ID: 8126147
    [Abstract] [Full Text] [Related]

  • 16. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [Abstract] [Full Text] [Related]

  • 17. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes.
    Paolisso G, Tagliamonte MR, Rizzo MR, Gualdiero P, Saccomanno F, Gambardella A, Giugliano D, D'Onofrio F, Howard BV.
    Diabetologia; 1998 Oct; 41(10):1127-32. PubMed ID: 9794097
    [Abstract] [Full Text] [Related]

  • 18. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.
    Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P, Bolli GB.
    Diabetes; 1997 Jun; 46(6):1010-6. PubMed ID: 9166673
    [Abstract] [Full Text] [Related]

  • 19. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A, Skött P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H.
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [Abstract] [Full Text] [Related]

  • 20. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
    Consoli A, Nurjhan N, Capani F, Gerich J.
    Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.